Gracell Bio Ownership 2024 | Who Owns Gracell Bio Now?
Institutional Ownership
65.72%
Insider Ownership
16.39%
Retail Ownership
17.89%
Institutional Holders
69.00
Gracell Bio Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -13,999 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -511,953 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -7,194 | -100.00% | - | Mar 31, 2024 |
| BARCLAYS PLC | - | - | - | -10,517 | -100.00% | - | Mar 31, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -150 | -100.00% | - | Mar 31, 2024 |
| CITIGROUP INC | - | - | - | -1,316 | -100.00% | - | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -18,112 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | - | - | - | -78,119 | -100.00% | - | Mar 31, 2024 |
| INVESCO LTD. | - | - | - | -62,863 | -100.00% | - | Mar 31, 2024 |
| GABELLI & CO INVESTMENT ADVISERS, INC. | - | - | - | -34,300 | -100.00% | - | Mar 31, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -25,030 | -100.00% | - | Mar 31, 2024 |
| TEMASEK HOLDINGS (PRIVATE) LTD | - | - | - | -9,588,863 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -39,300 | -100.00% | - | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | - | - | - | -9,308,726 | -100.00% | - | Mar 31, 2024 |
| GABELLI FUNDS LLC | - | - | - | -39,850 | -100.00% | - | Mar 31, 2024 |
| CSS LLC/IL | - | - | - | -73,000 | -100.00% | - | Mar 31, 2024 |
| HARVEST MANAGEMENT LLC | - | - | - | -400,000 | -100.00% | - | Mar 31, 2024 |
| EQUITEC PROPRIETARY MARKETS, LLC | - | - | - | -7,400 | -100.00% | - | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -1,350,000 | -100.00% | - | Mar 31, 2024 |
| AQR ARBITRAGE LLC | - | - | - | -130,779 | -100.00% | - | Mar 31, 2024 |
Gracell Bio's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -13,999 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -511,953 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -7,194 | -100.00% | - | Mar 31, 2024 |
| BARCLAYS PLC | - | - | - | -10,517 | -100.00% | - | Mar 31, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -150 | -100.00% | - | Mar 31, 2024 |
| CITIGROUP INC | - | - | - | -1,316 | -100.00% | - | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -18,112 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | - | - | - | -78,119 | -100.00% | - | Mar 31, 2024 |
| INVESCO LTD. | - | - | - | -62,863 | -100.00% | - | Mar 31, 2024 |
| GABELLI & CO INVESTMENT ADVISERS, INC. | - | - | - | -34,300 | -100.00% | - | Mar 31, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -25,030 | -100.00% | - | Mar 31, 2024 |
| TEMASEK HOLDINGS (PRIVATE) LTD | - | - | - | -9,588,863 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -39,300 | -100.00% | - | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | - | - | - | -9,308,726 | -100.00% | - | Mar 31, 2024 |
| GABELLI FUNDS LLC | - | - | - | -39,850 | -100.00% | - | Mar 31, 2024 |
| CSS LLC/IL | - | - | - | -73,000 | -100.00% | - | Mar 31, 2024 |
| HARVEST MANAGEMENT LLC | - | - | - | -400,000 | -100.00% | - | Mar 31, 2024 |
| EQUITEC PROPRIETARY MARKETS, LLC | - | - | - | -7,400 | -100.00% | - | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -1,350,000 | -100.00% | - | Mar 31, 2024 |
| AQR ARBITRAGE LLC | - | - | - | -130,779 | -100.00% | - | Mar 31, 2024 |
The largest Gracell Bio shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of Gracell Bio (GRCL), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DAIWA SECURITIES GROUP INC. | - | - | - | -146 | -100.00% | - | Mar 31, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -150 | -100.00% | - | Mar 31, 2024 |
| EAGLE BAY ADVISORS LLC | - | - | - | -210 | -100.00% | - | Mar 31, 2024 |
| CITADEL ADVISORS LLC | - | - | - | -500 | -100.00% | - | Mar 31, 2024 |
| CITIGROUP INC | - | - | - | -1,316 | -100.00% | - | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -1,622 | -100.00% | - | Mar 31, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -5,465 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -7,194 | -100.00% | - | Mar 31, 2024 |
| EQUITEC PROPRIETARY MARKETS, LLC | - | - | - | -7,400 | -100.00% | - | Mar 31, 2024 |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | - | - | - | -8,405 | -100.00% | - | Mar 31, 2024 |
| FNY INVESTMENT ADVISERS, LLC | - | - | - | -10,000 | -100.00% | - | Mar 31, 2024 |
| BARCLAYS PLC | - | - | - | -10,517 | -100.00% | - | Mar 31, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -13,999 | -100.00% | - | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -18,112 | -100.00% | - | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -20,182 | -100.00% | - | Mar 31, 2024 |
| YAKIRA CAPITAL MANAGEMENT, INC. | - | - | - | -21,924 | -100.00% | - | Mar 31, 2024 |
| PENDERFUND CAPITAL MANAGEMENT LTD. | - | - | - | -22,570 | -100.00% | - | Mar 31, 2024 |
| OASIS MANAGEMENT CO LTD. | - | - | - | -25,000 | -100.00% | - | Mar 31, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -25,030 | -100.00% | - | Mar 31, 2024 |
| GTS SECURITIES LLC | - | - | - | -25,144 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Gracell Bio's largest institutional buyer is DAIWA SECURITIES GROUP INC.. The company purchased -0.15K stocks of GRCL, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TEMASEK HOLDINGS (PRIVATE) LTD | - | - | - | -9,588,863 | -100.00% | - | Mar 31, 2024 |
| VIVO CAPITAL, LLC | - | - | - | -9,546,485 | -100.00% | - | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | - | - | - | -9,308,726 | -100.00% | - | Mar 31, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | - | - | - | -5,001,580 | -100.00% | - | Mar 31, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | - | - | - | -4,514,786 | -100.00% | - | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -2,191,417 | -100.00% | - | Mar 31, 2024 |
| BAKER BROS. ADVISORS LP | - | - | - | -2,080,000 | -100.00% | - | Mar 31, 2024 |
| PENTWATER CAPITAL MANAGEMENT LP | - | - | - | -1,461,000 | -100.00% | - | Mar 31, 2024 |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | - | - | - | -1,375,000 | -100.00% | - | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -1,350,000 | -100.00% | - | Mar 31, 2024 |
| TIG ADVISORS, LLC | - | - | - | -1,279,595 | -100.00% | - | Mar 31, 2024 |
| ALPINE ASSOCIATES MANAGEMENT INC. | - | - | - | -1,278,454 | -100.00% | - | Mar 31, 2024 |
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -596,611 | -100.00% | - | Mar 31, 2024 |
| BLACKROCK INC. | - | - | - | -539,973 | -100.00% | - | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -517,274 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -511,953 | -100.00% | - | Mar 31, 2024 |
| LMR PARTNERS LLP | - | - | - | -510,001 | -100.00% | - | Mar 31, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -502,936 | -100.00% | - | Mar 31, 2024 |
| MMCAP INTERNATIONAL INC. SPC | - | - | - | -451,172 | -100.00% | - | Mar 31, 2024 |
| HARVEST MANAGEMENT LLC | - | - | - | -400,000 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Gracell Bio's biggest institutional seller is TEMASEK HOLDINGS (PRIVATE) LTD. The company sold -9.59M shares of GRCL, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TEMASEK HOLDINGS (PRIVATE) LTD | - | - | - | -9,588,863 | -100.00% | - | Mar 31, 2024 |
| VIVO CAPITAL, LLC | - | - | - | -9,546,485 | -100.00% | - | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | - | - | - | -9,308,726 | -100.00% | - | Mar 31, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | - | - | - | -5,001,580 | -100.00% | - | Mar 31, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | - | - | - | -4,514,786 | -100.00% | - | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -2,191,417 | -100.00% | - | Mar 31, 2024 |
| BAKER BROS. ADVISORS LP | - | - | - | -2,080,000 | -100.00% | - | Mar 31, 2024 |
| PENTWATER CAPITAL MANAGEMENT LP | - | - | - | -1,461,000 | -100.00% | - | Mar 31, 2024 |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | - | - | - | -1,375,000 | -100.00% | - | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -1,350,000 | -100.00% | - | Mar 31, 2024 |
| TIG ADVISORS, LLC | - | - | - | -1,279,595 | -100.00% | - | Mar 31, 2024 |
| ALPINE ASSOCIATES MANAGEMENT INC. | - | - | - | -1,278,454 | -100.00% | - | Mar 31, 2024 |
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -596,611 | -100.00% | - | Mar 31, 2024 |
| BLACKROCK INC. | - | - | - | -539,973 | -100.00% | - | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -517,274 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -511,953 | -100.00% | - | Mar 31, 2024 |
| LMR PARTNERS LLP | - | - | - | -510,001 | -100.00% | - | Mar 31, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -502,936 | -100.00% | - | Mar 31, 2024 |
| MMCAP INTERNATIONAL INC. SPC | - | - | - | -451,172 | -100.00% | - | Mar 31, 2024 |
| HARVEST MANAGEMENT LLC | - | - | - | -400,000 | -100.00% | - | Mar 31, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -266,667 | -100.00% | - | Mar 31, 2024 |
| MARSHALL WACE, LLP | - | - | - | -192,465 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -191,269 | -100.00% | - | Mar 31, 2024 |
| AQR ARBITRAGE LLC | - | - | - | -130,779 | -100.00% | - | Mar 31, 2024 |
| UBS GROUP AG | - | - | - | -125,681 | -100.00% | - | Mar 31, 2024 |
| WEISS ASSET MANAGEMENT LP | - | - | - | -109,400 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -87,598 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | - | - | - | -78,119 | -100.00% | - | Mar 31, 2024 |
| CSS LLC/IL | - | - | - | -73,000 | -100.00% | - | Mar 31, 2024 |
| INVESCO LTD. | - | - | - | -62,863 | -100.00% | - | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -59,063 | -100.00% | - | Mar 31, 2024 |
| FIFTH LANE CAPITAL, LP | - | - | - | -58,336 | -100.00% | - | Mar 31, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | - | - | - | -50,000 | -100.00% | - | Mar 31, 2024 |
| JBF CAPITAL, INC. | - | - | - | -50,000 | -100.00% | - | Mar 31, 2024 |
| PATHSTONE HOLDINGS, LLC | - | - | - | -49,158 | -100.00% | - | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -43,334 | -100.00% | - | Mar 31, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -40,974 | -100.00% | - | Mar 31, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -40,974 | -100.00% | - | Mar 31, 2024 |
| GABELLI FUNDS LLC | - | - | - | -39,850 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -39,300 | -100.00% | - | Mar 31, 2024 |
| GABELLI & CO INVESTMENT ADVISERS, INC. | - | - | - | -34,300 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | - | - | - | -33,600 | -100.00% | - | Mar 31, 2024 |
| GTS SECURITIES LLC | - | - | - | -25,144 | -100.00% | - | Mar 31, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -25,030 | -100.00% | - | Mar 31, 2024 |
| OASIS MANAGEMENT CO LTD. | - | - | - | -25,000 | -100.00% | - | Mar 31, 2024 |
| PENDERFUND CAPITAL MANAGEMENT LTD. | - | - | - | -22,570 | -100.00% | - | Mar 31, 2024 |
| YAKIRA CAPITAL MANAGEMENT, INC. | - | - | - | -21,924 | -100.00% | - | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -20,182 | -100.00% | - | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -18,112 | -100.00% | - | Mar 31, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -13,999 | -100.00% | - | Mar 31, 2024 |
| BARCLAYS PLC | - | - | - | -10,517 | -100.00% | - | Mar 31, 2024 |
| FNY INVESTMENT ADVISERS, LLC | - | - | - | -10,000 | -100.00% | - | Mar 31, 2024 |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | - | - | - | -8,405 | -100.00% | - | Mar 31, 2024 |
| EQUITEC PROPRIETARY MARKETS, LLC | - | - | - | -7,400 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -7,194 | -100.00% | - | Mar 31, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -5,465 | -100.00% | - | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -1,622 | -100.00% | - | Mar 31, 2024 |
| CITIGROUP INC | - | - | - | -1,316 | -100.00% | - | Mar 31, 2024 |
| CITADEL ADVISORS LLC | - | - | - | -500 | -100.00% | - | Mar 31, 2024 |
| EAGLE BAY ADVISORS LLC | - | - | - | -210 | -100.00% | - | Mar 31, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -150 | -100.00% | - | Mar 31, 2024 |
| DAIWA SECURITIES GROUP INC. | - | - | - | -146 | -100.00% | - | Mar 31, 2024 |
Gracell Bio's largest sold out institutional shareholder by shares sold is TEMASEK HOLDINGS (PRIVATE) LTD, sold -9.59M shares, valued at -, as of undefined.
Gracell Bio Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Comstock Funds, Inc. | 0.14% | 3,000 | 3,000 | - | Jan 31, 2024 |
| BlackRock Health Sciences Trust II | 0.13% | 340,846 | - | - | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.12% | 256,335 | - | - | Feb 29, 2024 |
| EMERGING MARKETS GROWTH FUND INC | 0.09% | 1,336,443 | - | - | Mar 31, 2024 |
| Gabelli 787 Fund, Inc. | 0.07% | 6,000 | 6,000 | - | Jan 31, 2024 |
| Federated Hermes Equity Funds | 0.05% | 1,010,815 | - | - | Jan 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.03% | 2,082,916 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.02% | 24,728 | - | - | Jan 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 18,728 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 303,078 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 147,966 | - | - | Feb 29, 2024 |
| BlackRock ETF Trust | 0.00% | 1,889 | - | - | Jan 31, 2024 |
| GDL FUND | 0.00% | 2,000 | 2,000 | - | Dec 29, 2023 |
| BLACKROCK LARGE CAP SERIES FUNDS, INC. | 0.00% | 64,671 | - | - | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 36,220 | - | - | Mar 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 46,579 | - | - | Mar 31, 2024 |
| GABELLI INVESTOR FUNDS INC | 0.00% | 2,000 | 2,000 | - | Dec 29, 2023 |
| ETF Series Solutions | 0.00% | 16,681 | - | - | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 57,046 | -7,138 | -11.12% | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 68,825 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 43,334 | - | - | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 896 | - | - | Jan 31, 2024 |
| HARTFORD MUTUAL FUNDS INC/CT | 0.00% | 358,099 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 8,959 | - | - | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 381,036 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 4,344 | - | - | Feb 29, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 4,746 | - | - | Feb 29, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 7,748 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 6,602 | 3,301 | 100.00% | Jan 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 17,000 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 1,194 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 2,000 | - | - | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 200 | - | - | Mar 31, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 222 | - | - | Mar 31, 2024 |
Gracell Bio's largest mutual fund holder by % of total assets is "Comstock Funds, Inc.", owning 3.00K shares, compromising 0.14% of its total assets.
Gracell Bio Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Dec, 23 | 69 | 60.47% |
| 30 Sep, 23 | 43 | 22.86% |
| 30 Jun, 23 | 35 | 12.90% |
| 31 Mar, 23 | 31 | - |
| 31 Dec, 22 | 31 | 3.33% |
| 30 Sep, 22 | 30 | -6.25% |
| 30 Jun, 22 | 32 | - |
| 31 Mar, 22 | 32 | -8.57% |
| 31 Dec, 21 | 35 | 2.94% |
| 30 Sep, 21 | 34 | 9.68% |
| 30 Jun, 21 | 31 | -13.89% |
| 31 Mar, 21 | 36 | - |
As of 31 Dec 23, 69 institutions are holding Gracell Bio's shares, representing an increase of 60.47% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Dec, 23 | 55,155,639 | 13.94% |
| 30 Sep, 23 | 48,406,779 | 50.21% |
| 30 Jun, 23 | 32,226,885 | 6.47% |
| 31 Mar, 23 | 30,269,482 | -0.55% |
| 31 Dec, 22 | 30,437,070 | -0.28% |
| 30 Sep, 22 | 30,521,692 | -4.52% |
| 30 Jun, 22 | 31,965,831 | -0.79% |
| 31 Mar, 22 | 32,219,566 | -4.02% |
| 31 Dec, 21 | 33,569,330 | 3.44% |
| 30 Sep, 21 | 32,453,120 | 56.29% |
| 30 Jun, 21 | 20,764,712 | -0.32% |
| 31 Mar, 21 | 20,831,853 | - |
Gracell Bio (GRCL) has 55.16M shares outstanding as of 31 Dec 23, up 13.94% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Dec, 23 | 65.72% | 1.31% |
| 30 Sep, 23 | 70.90% | 3.13% |
| 30 Jun, 23 | 47.60% | 2.38% |
| 31 Mar, 23 | 44.70% | 2.21% |
| 31 Dec, 22 | 44.96% | 2.21% |
| 30 Sep, 22 | 45.10% | 2.02% |
| 30 Jun, 22 | 47.24% | 2.08% |
| 31 Mar, 22 | 47.64% | 1.83% |
| 31 Dec, 21 | 51.04% | 2.19% |
| 30 Sep, 21 | 48.22% | 5.06% |
| 30 Jun, 21 | 30.88% | 2.64% |
| 31 Mar, 21 | 34.21% | - |
As of 31 Dec 23, Gracell Bio is held by 65.72% institutional shareholders, representing a 1.31% growth compared to 30 Sep 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Dec, 23 | 49 | 81.48% |
| 30 Sep, 23 | 27 | 28.57% |
| 30 Jun, 23 | 21 | 16.67% |
| 31 Mar, 23 | 18 | 50.00% |
| 31 Dec, 22 | 12 | - |
| 30 Sep, 22 | 12 | -7.69% |
| 30 Jun, 22 | 13 | -31.58% |
| 31 Mar, 22 | 19 | -9.52% |
| 31 Dec, 21 | 21 | 31.25% |
| 30 Sep, 21 | 16 | 6.67% |
| 30 Jun, 21 | 15 | -58.33% |
| 31 Mar, 21 | 36 | - |
49 institutional shareholders have increased their position in GRCL stock as of 31 Dec 23 compared to 27 in the previous quarter (a 81.48% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Dec, 23 | 10 | -23.08% |
| 30 Sep, 23 | 13 | 8.33% |
| 30 Jun, 23 | 12 | 50.00% |
| 31 Mar, 23 | 8 | -27.27% |
| 31 Dec, 22 | 11 | 10.00% |
| 30 Sep, 22 | 10 | - |
| 30 Jun, 22 | 10 | 42.86% |
| 31 Mar, 22 | 7 | -22.22% |
| 31 Dec, 21 | 9 | -25.00% |
| 30 Sep, 21 | 12 | 33.33% |
| 30 Jun, 21 | 9 | - |
| 31 Mar, 21 | - | - |
10 institutional shareholders have reduced their position in GRCL stock as of 31 Dec 23 compared to 13 in the previous quarter (a -23.08% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 23 | 69 | 60.47% | 55,155,639 | 13.94% | 65.72% | 1.31% | 49 | 81.48% | 10 | -23.08% |
| 30 Sep, 23 | 43 | 22.86% | 48,406,779 | 50.21% | 70.90% | 3.13% | 27 | 28.57% | 13 | 8.33% |
| 30 Jun, 23 | 35 | 12.90% | 32,226,885 | 6.47% | 47.60% | 2.38% | 21 | 16.67% | 12 | 50.00% |
| 31 Mar, 23 | 31 | - | 30,269,482 | -0.55% | 44.70% | 2.21% | 18 | 50.00% | 8 | -27.27% |
| 31 Dec, 22 | 31 | 3.33% | 30,437,070 | -0.28% | 44.96% | 2.21% | 12 | - | 11 | 10.00% |
| 30 Sep, 22 | 30 | -6.25% | 30,521,692 | -4.52% | 45.10% | 2.02% | 12 | -7.69% | 10 | - |
| 30 Jun, 22 | 32 | - | 31,965,831 | -0.79% | 47.24% | 2.08% | 13 | -31.58% | 10 | 42.86% |
| 31 Mar, 22 | 32 | -8.57% | 32,219,566 | -4.02% | 47.64% | 1.83% | 19 | -9.52% | 7 | -22.22% |
| 31 Dec, 21 | 35 | 2.94% | 33,569,330 | 3.44% | 51.04% | 2.19% | 21 | 31.25% | 9 | -25.00% |
| 30 Sep, 21 | 34 | 9.68% | 32,453,120 | 56.29% | 48.22% | 5.06% | 16 | 6.67% | 12 | 33.33% |
| 30 Jun, 21 | 31 | -13.89% | 20,764,712 | -0.32% | 30.88% | 2.64% | 15 | -58.33% | 9 | - |
| 31 Mar, 21 | 36 | - | 20,831,853 | - | 34.21% | - | 36 | - | - | - |
Gracell Bio Peer Ownership
| Ticker | Company |
|---|---|
| XFOR | X4 Pharmaceuticals, Inc. |
| DBTX | Decibel Therapeutics, Inc. |
| NXTC | NextCure, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| ERAS | Erasca, Inc. |
| CTMX | CytomX Therapeutics, Inc. |
| SPRO | Spero Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| BOLT | Bolt Biotherapeutics, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ASMB | Assembly Biosciences, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| NLTX | Neurogene Inc. |
| CHRS | Coherus BioSciences, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
GRCL Ownership FAQ
Who Owns Gracell Bio?
Gracell Bio is owned by institutional shareholders (65.72%), insiders (16.39%), and public (17.89%). The largest institutional shareholder of Gracell Bio is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is Comstock Funds, Inc. (0.14% of total shares).
Who are the major institutional shareholders of Gracell Bio?
Gracell Bio's major institutional shareholders are JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, BARCLAYS PLC, and PNC FINANCIAL SERVICES GROUP, INC.. The top five shareholders own together 0% of the company's share outstanding.
How many Gracell Bio shareholders are there?
As of Dec 2023, there are 69 institutional shareholders of Gracell Bio.
What percentage of Gracell Bio is owned by JPMORGAN CHASE & CO?
JPMORGAN CHASE & CO owns 0 shares of Gracell Bio, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).
What percentage of Gracell Bio is owned by BANK OF AMERICA CORP /DE/?
As of Mar 2024, BANK OF AMERICA CORP /DE/ holds 0 shares of Gracell Bio (GRCL), compromising 0% of the company, valued at $0.
What percentage of Gracell Bio is owned by WELLS FARGO & COMPANY/MN?
WELLS FARGO & COMPANY/MN is the third largest holder of Gracell Bio. The company owns 0 of the company's shares outstanding (worth $0).